OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics
Archana Sharma, Diksha Sharma, Neha Saini, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 847-889
Open Access | Times Cited: 13

Showing 13 citing articles:

5-Ene-2-Arylaminothiazol-4(5h)-Ones Induce Apoptosis in Breast Cancer Cell
Rostyslav Dudchak, M Podolak, Ivan Sydorenko, et al.
(2025)
Closed Access

Green synthesis of 1,3-Thiazolidin-4-ones derivatives by using acid-activated montmorillonite as catalyst
Mustafa M. Hasan AL-Abayechi, Abbas Al‐Nayili, Asim A. Balakit
Inorganic Chemistry Communications (2024) Vol. 161, pp. 112076-112076
Closed Access | Times Cited: 4

New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors
Antonella Messore, Paolo Malune, Elisa Patacchini, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 650-650
Open Access | Times Cited: 2

Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 6

Redefining the significance of quinoline containing compounds as potent VEGFR-2 inhibitors for cancer therapy
Jurnal Reang, Vinita Sharma, Vivek Yadav, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 7, pp. 1079-1099
Closed Access | Times Cited: 1

Exploring Thiazolidine-2,4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights
Mayavan Viji, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024), pp. 140529-140529
Closed Access | Times Cited: 1

In silico study of five new sulfonamide derivatives bearing a thiazolidine-4-one moiety: targeting carbonic anhydrase IX
Zahraa Falah Naji, Noor H. Naser
Review of Clinical Pharmacology and Pharmacokinetics - International Edition (2024) Vol. 38, Iss. 2, pp. 161-173
Open Access

Synthesis, Characterization of Different Five-Membered Heterocyclic Derivatives, Evaluated Their as Antioxidant, and In Vitro Antimicrobial Agents
Asmaa Abdulbaqi Maryoosh, Oday H. R. Al-Jeilawi
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 4, pp. 1551-1562
Closed Access

Anti-Cancer Activity, DFT and molecular docking study of new BisThiazolidine amide
Haider A. Omran, Ahmed A. Majed, Kawkab Ali Hussein, et al.
Results in Chemistry (2024), pp. 101835-101835
Open Access

PEG-Polymeric Nanocarriers Alleviate the Immunosuppressive Effects of Free 4-Thiazolidinone-Based Chemotherapeutics on T Lymphocyte Function and Cytokine Production
Jana Tulinská, Lesya Коbylinska, Miroslava Lehotská Mikušová, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 14021-14041
Open Access

Page 1

Scroll to top